Search Results

Norethindrone dosing for adequate menstrual suppression in adolescents.

• Authors : Rager TL; University of Michigan Medical School, Ann Arbor, MI, USA.; Compton SD

Subjects: Norethindrone*/Norethindrone*/Norethindrone*/adverse effects ; Menorrhagia*/Menorrhagia*/Menorrhagia*/chemically induced; Female

• Source: Journal of pediatric endocrinology & metabolism : JPEM [J Pediatr Endocrinol Metab] 2023 Jun 08; Vol. 36 (8), pp. 732-739. Date of Electronic Publication: 2023 Jun 08 (Print Publisher: Walter de Gruyter Country of Publication: Germany NLM ID: 9508900 Publication Model: Electronic-Print Cited Medium: Internet ISSN:

Record details

Correspondence on 'Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding' by DeLoughery et al .

• Authors : Vafapour P; Faculty of Medicine and Dentistry, Barts and The London School of Medicine and Dentistry, London, UK .; Mohammed RA

Subjects: Menorrhagia*/Menorrhagia*/Menorrhagia*/diagnosis; Female ; Humans

• Source: BMJ sexual & reproductive health [BMJ Sex Reprod Health] 2024 Jan 09; Vol. 50 (1), pp. 71. Date of Electronic Publication: 2024 Jan 09.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101715577 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.

• Authors : Neblett MF 2nd; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, the Department of Physiology and Biomedical Engineering, the Division of Endocrinology, Department of Medicine, the Department of Surgery, and the Women's Health Research Center, Mayo Clinic, and Mayo Clinic Alix School of Medicine, Rochester, Minnesota.; Stewart EA

Subjects: Menorrhagia*/Menorrhagia*/Menorrhagia*/etiology ; Uterine Neoplasms*/Uterine Neoplasms*/Uterine Neoplasms*/drug therapy ; Uterine Neoplasms*/Uterine Neoplasms*/Uterine Neoplasms*/complications

• Source: Obstetrics and gynecology [Obstet Gynecol] 2023 May 01; Vol. 141 (5), pp. 901-910. Date of Electronic Publication: 2023 Apr 05.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401101 Publication Model: Print-Electronic Cited Medium:

Record details

Myfembree for fibroid-associated heavy menstrual bleeding.

Subjects: Estradiol/Estradiol/Estradiol/*therapeutic use ; Leiomyoma/Leiomyoma/Leiomyoma/*complications ; Menorrhagia/Menorrhagia/Menorrhagia/*drug therapy

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 Aug 09; Vol. 63 (1630), pp. 121-123.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.

• Authors : Syed YY; Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. .

Subjects: Menorrhagia*/Menorrhagia*/Menorrhagia*/complications ; Menorrhagia*/Menorrhagia*/Menorrhagia*/drug therapy ; Uterine Neoplasms*/Uterine Neoplasms*/Uterine Neoplasms*/complications

• Source: Drugs [Drugs] 2022 Oct; Vol. 82 (15), pp. 1549-1556. Date of Electronic Publication: 2022 Nov 04.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Oriahnn for fibroid-associated heavy menstrual bleeding.

Subjects: Estradiol/Estradiol/Estradiol/*therapeutic use ; Hydrocarbons, Fluorinated/Hydrocarbons, Fluorinated/Hydrocarbons, Fluorinated/*therapeutic use ; Leiomyoma/Leiomyoma/Leiomyoma/*complications

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 Apr 05; Vol. 63 (1621), pp. 51-52.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.

• Authors : Donnez J; Société de Recherche pour l'infertilité, Catholic University of Louvain, Brussels, Belgium.; Taylor HS

Subjects: Leiomyoma*/Leiomyoma*/Leiomyoma*/drug therapy ; Menorrhagia*/Menorrhagia*/Menorrhagia*/complications ; Menorrhagia*/Menorrhagia*/Menorrhagia*/etiology

• Source: Lancet (London, England) [Lancet] 2022 Sep 17; Vol. 400 (10356), pp. 896-907.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic)

Record details

Autoimmune progesterone dermatitis as a clue to refractory jaundice in a young woman.

• Authors : Afra TP; Departments of, Department of, Dermatology, IQRAA International Hospital and Research Centre, Calicut, India.; Razmi T M

Subjects: Autoimmune Diseases/Autoimmune Diseases/Autoimmune Diseases/*diagnosis ; Dermatitis/Dermatitis/Dermatitis/*diagnosis ; Exanthema/Exanthema/Exanthema/*diagnosis Autoimmune progesterone dermatitis

• Source: Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jan; Vol. 46 (1), pp. 163-164. Date of Electronic Publication: 2020 Jul 27.Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Progestogen-releasing intrauterine systems for heavy menstrual bleeding.

• Authors : Bofill Rodriguez M; Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.; Lethaby A

Subjects: Intrauterine Devices, Medicated*; Levonorgestrel/Levonorgestrel/Levonorgestrel/*therapeutic use ; Menorrhagia/Menorrhagia/Menorrhagia/*drug therapy

• Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Jun 12; Vol. 6. Cochrane AN: CD002126. Date of Electronic Publication: 2020 Jun 12.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.

• Authors : Simon JA; George Washington University, IntimMedicine Specialists, Washington, DC; University of Illinois at Chicago, Chicago, Illinois

Subjects: Estradiol/Estradiol/Estradiol/*administration & dosage ; Hydrocarbons, Fluorinated/Hydrocarbons, Fluorinated/Hydrocarbons, Fluorinated/*administration & dosage ; Leiomyoma/Leiomyoma/Leiomyoma/*drug therapy

• Source: Obstetrics and gynecology [Obstet Gynecol] 2020 Jun; Vol. 135 (6), pp. 1313-1326.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401101 Publication Model: Print Cited Medium: Internet ISSN:

Record details